Condition: Post-traumatic Stress Disorder · Insomnia · Sponsor: VA Office of Research and Development
This is a preliminary randomized, double-blind, placebo-controlled trial comparing pimavanserin 34mg at bedtime vs. placebo for the treatment of insomnia associated with post-traumatic stress disorder.
This description comes directly from the study's public registry record.
Melissa B Jones, MD · (713) 794-1414 · Melissa.Jones10@va.gov
Ricardo E Jorge, MD · (713) 791-1414 · Ricardo.Jorge@va.gov
Always discuss trial participation with your own doctor first.
| Michael E. DeBakey VA Medical Center, Houston, TX | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05441280